Physician profile
Frederica Su
NPI 1811417173
$1,610.98
in general payments reported to CMS, 2019-2025
9 companies · $550 in 2025
The $550 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $81.78 · 2021: $156 · 2022: $70.67 · 2023: $175 · 2024: $578 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,302.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $996.01 | 2022-2025 | Evenity, Prolia, Prolia |
| Novo Nordisk INC | $170.53 | 2024-2025 | Ozempic, Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $143.43 | 2021 | |
| Lilly USA, LLC | $89.04 | 2024-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $68.68 | 2020 | |
| Glaxosmithkline, LLC. | $46.79 | 2021-2025 | Trelegy Ellipta |
| Pfizer INC. | $44.61 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.27 | 2020-2024 | Jardiance |
| Abbvie INC. | $13.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederica Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.